Long-Term Efficacy and Safety of Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Phase III Open-Label Extension Trial (LIBERTY AD PED-OLE)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1888
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Long-Term Efficacy and Safety of Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Phase III Open-Label Extension Trial (LIBERTY AD PED-OLE) ; volume:23 ; number:3 ; day:14 ; month:5 ; year:2022 ; pages:365-383 ; date:5.2022
American journal of clinical dermatology ; 23, Heft 3 (14.5.2022), 365-383, 5.2022
- Creator
-
Blauvelt, Andrew
Guttman-Yassky, Emma
Paller, Amy S.
Simpson, Eric L.
Cork, Michael J.
Weisman, Jamie
Browning, John
Soong, Weily
Sun, Xian
Chen, Zhen
Kosloski, Matthew P.
Kamal, Mohamed A.
Delevry, Dimittri
Chuang, Chien-Chia
O’Malley, John T.
Bansal, Ashish
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40257-022-00683-2
- URN
-
urn:nbn:de:101:1-2022072919525748683777
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Blauvelt, Andrew
- Guttman-Yassky, Emma
- Paller, Amy S.
- Simpson, Eric L.
- Cork, Michael J.
- Weisman, Jamie
- Browning, John
- Soong, Weily
- Sun, Xian
- Chen, Zhen
- Kosloski, Matthew P.
- Kamal, Mohamed A.
- Delevry, Dimittri
- Chuang, Chien-Chia
- O’Malley, John T.
- Bansal, Ashish
- SpringerLink (Online service)
Other Objects (12)
Consistency of Response to Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis Over 1 Year
Protein design for industrial strain development : the case of amino acid production
Dupilumab with Topical Corticosteroids Provides Rapid and Sustained Improvement in Adults with Moderate-to-Severe Atopic Dermatitis Across Anatomic Regions Over 52 Weeks
Energy scavenging from the diurnal cycle with a temperature-doubler circuit and a self-adaptive photonic design
Data analytics approach for travel time reliability pattern analysis and prediction
Toward glycerol biorefinery: metabolic engineering for the production of biofuels and chemicals from glycerol
Immune-Mediated Uveitis and Lifestyle Factors: A Review
Extracting bus transit boarding stop information using smart card transaction data
The effect of caring ethical climate on employees’ knowledge-hiding behavior: evidence from Chinese construction firms
Infections in Children Aged 6 Months to 5 Years Treated with Dupilumab in a Placebo-Controlled Clinical Trial of Moderate-to-Severe Atopic Dermatitis
Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry
Efficacy of Dupilumab in Atopic Dermatitis: The Patient’s Perspective
Consistency of Response to Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis Over 1 Year
Protein design for industrial strain development : the case of amino acid production
Dupilumab with Topical Corticosteroids Provides Rapid and Sustained Improvement in Adults with Moderate-to-Severe Atopic Dermatitis Across Anatomic Regions Over 52 Weeks
Energy scavenging from the diurnal cycle with a temperature-doubler circuit and a self-adaptive photonic design
Data analytics approach for travel time reliability pattern analysis and prediction
Toward glycerol biorefinery: metabolic engineering for the production of biofuels and chemicals from glycerol
Immune-Mediated Uveitis and Lifestyle Factors: A Review
Extracting bus transit boarding stop information using smart card transaction data
The effect of caring ethical climate on employees’ knowledge-hiding behavior: evidence from Chinese construction firms
Infections in Children Aged 6 Months to 5 Years Treated with Dupilumab in a Placebo-Controlled Clinical Trial of Moderate-to-Severe Atopic Dermatitis
Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry
Efficacy of Dupilumab in Atopic Dermatitis: The Patient’s Perspective
Consistency of Response to Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis Over 1 Year
Protein design for industrial strain development : the case of amino acid production
Dupilumab with Topical Corticosteroids Provides Rapid and Sustained Improvement in Adults with Moderate-to-Severe Atopic Dermatitis Across Anatomic Regions Over 52 Weeks
Energy scavenging from the diurnal cycle with a temperature-doubler circuit and a self-adaptive photonic design
Data analytics approach for travel time reliability pattern analysis and prediction
Toward glycerol biorefinery: metabolic engineering for the production of biofuels and chemicals from glycerol
Immune-Mediated Uveitis and Lifestyle Factors: A Review
Extracting bus transit boarding stop information using smart card transaction data
The effect of caring ethical climate on employees’ knowledge-hiding behavior: evidence from Chinese construction firms
Infections in Children Aged 6 Months to 5 Years Treated with Dupilumab in a Placebo-Controlled Clinical Trial of Moderate-to-Severe Atopic Dermatitis
Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry